Register to chat with like-minded investors on our interactive forums.

Get Started

GLPG

Galapagos (GLPG)

Galapagos

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:EU:GLPG

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 Next >>

Date	Time	Source	Headline	Symbol	Company
05/04/2023	4:01PM	GlobeNewswire Inc.	Galapagos announces first quarter 2023 financial results	EU:GLPG	Galapagos
05/02/2023	4:01PM	GlobeNewswire Inc.	Galapagos announces departure of Bart Filius, Chief Operating Officer and Chief Financial Officer	EU:GLPG	Galapagos
05/02/2023	4:01PM	GlobeNewswire Inc.	Galapagos announces departure of Bart Filius, Chief Operating Officer and Chief Financial Officer	EU:GLPG	Galapagos
04/26/2023	4:01PM	GlobeNewswire Inc.	Galapagos initiates Phase 3 program with filgotinib in patients with active axial spondyloarthritis	EU:GLPG	Galapagos
04/26/2023	4:01PM	GlobeNewswire Inc.	Galapagos initiates Phase 3 program with filgotinib in patients with active axial spondyloarthritis	EU:GLPG	Galapagos
04/25/2023	4:01PM	GlobeNewswire Inc.	Galapagos’ shareholders approve all resolutions proposed by the Board of Directors at the annual shareholders’ meeting	EU:GLPG	Galapagos
04/25/2023	4:01PM	GlobeNewswire Inc.	Galapagos’ shareholders approve all resolutions proposed by the Board of Directors at the annual shareholders’ meeting	EU:GLPG	Galapagos
03/30/2023	4:30PM	GlobeNewswire Inc.	Galapagos and NovAliX enter into an integrated drug discovery collaboration	EU:GLPG	Galapagos
03/30/2023	4:30PM	GlobeNewswire Inc.	Galapagos and NovAliX enter into an integrated drug discovery collaboration	EU:GLPG	Galapagos
03/23/2023	4:01PM	GlobeNewswire Inc.	Galapagos publishes 2022 annual report and announces Annual Shareholders’ Meeting	EU:GLPG	Galapagos
03/23/2023	4:01PM	GlobeNewswire Inc.	Galapagos publishes 2022 annual report and announces Annual Shareholders’ Meeting	EU:GLPG	Galapagos
03/20/2023	4:01PM	GlobeNewswire Inc.	Galapagos increases share capital through subscription right exercises	EU:GLPG	Galapagos
03/20/2023	4:01PM	GlobeNewswire Inc.	Galapagos increases share capital through subscription right exercises	EU:GLPG	Galapagos
02/27/2023	4:01PM	GlobeNewswire Inc.	Galapagos to present new data from long-term extension study of filgotinib in ulcerative colitis at annual ECCO congress 2023	EU:GLPG	Galapagos
02/27/2023	4:01PM	GlobeNewswire Inc.	Galapagos to present new data from long-term extension study of filgotinib in ulcerative colitis at annual ECCO congress 2023	EU:GLPG	Galapagos
02/23/2023	4:01PM	GlobeNewswire Inc.	Galapagos announces full year 2022 results and outlook for 2023	EU:GLPG	Galapagos
02/23/2023	4:01PM	GlobeNewswire Inc.	Galapagos announces full year 2022 results and outlook for 2023	EU:GLPG	Galapagos
02/09/2023	4:01PM	GlobeNewswire Inc.	Galapagos presented encouraging initial safety and efficacy data at 2023 EBMT-EHA for point-of-care manufactured CAR-T candidate, GLPG5201, in rrCLL	EU:GLPG	Galapagos
02/09/2023	4:01PM	GlobeNewswire Inc.	Galapagos presented encouraging initial safety and efficacy data at 2023 EBMT-EHA for point-of-care manufactured CAR-T candidate, GLPG5201, in rrCLL	EU:GLPG	Galapagos
02/08/2023	4:01PM	GlobeNewswire Inc.	Galapagos announces topline results from Phase 3 DIVERSITY trial of filgotinib in Crohn’s disease	EU:GLPG	Galapagos
02/08/2023	4:01PM	GlobeNewswire Inc.	Galapagos announces topline results from Phase 3 DIVERSITY trial of filgotinib in Crohn’s disease	EU:GLPG	Galapagos
01/10/2023	4:01PM	GlobeNewswire Inc.	Galapagos receives transparency notification from FMR LLC	EU:GLPG	Galapagos
01/10/2023	4:01PM	GlobeNewswire Inc.	Galapagos receives transparency notification from FMR LLC	EU:GLPG	Galapagos
01/03/2023	4:01PM	GlobeNewswire Inc.	Galapagos to present at 41th Annual J.P. Morgan Healthcare Conference	EU:GLPG	Galapagos
01/03/2023	4:01PM	GlobeNewswire Inc.	Galapagos to present at 41th Annual J.P. Morgan Healthcare Conference	EU:GLPG	Galapagos
12/23/2022	4:01PM	GlobeNewswire Inc.	Galapagos receives transparency notification from FMR LLC	EU:GLPG	Galapagos
12/23/2022	4:01PM	GlobeNewswire Inc.	Galapagos receives transparency notification from FMR LLC	EU:GLPG	Galapagos
12/22/2022	4:01PM	GlobeNewswire Inc.	Galapagos announces changes to Executive Committee	EU:GLPG	Galapagos
12/13/2022	1:00AM	GlobeNewswire Inc.	Galapagos and CellPoint presented encouraging initial data at ASH 2022 for GLPG5101, a CD19 CAR-T candidate manufactured at point-of-care	EU:GLPG	Galapagos
12/13/2022	1:00AM	GlobeNewswire Inc.	Galapagos and CellPoint presented encouraging initial data at ASH 2022 for GLPG5101, a CD19 CAR-T candidate manufactured at point-of-care	EU:GLPG	Galapagos

Showing the most relevant articles for your search:EU:GLPG

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 Next >>

Canopus Biopharma (PK)

Gold and GemStone Mining (PK)

Marketing Worldwide (PK)

Virexit Technologies (PK)

Bell Buckle (PK)

Ubiquitech Software (PK)

Brookmount Explorations (PK)

Fannie Mae (QB)

NioCorp Developments

Anavex Life Sciences

Seven Arts Entertainment (PK)

Decentral Life (PK)

Delayed Upgrade Clock